{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,20]],"date-time":"2026-05-20T10:06:28Z","timestamp":1779271588950,"version":"3.51.4"},"reference-count":43,"publisher":"Springer Science and Business Media LLC","issue":"10","license":[{"start":{"date-parts":[[2016,7,12]],"date-time":"2016-07-12T00:00:00Z","timestamp":1468281600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2016,7,12]],"date-time":"2016-07-12T00:00:00Z","timestamp":1468281600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Mol Psychiatry"],"published-print":{"date-parts":[[2017,10]]},"abstract":"<jats:title>Abstract<\/jats:title>\n          <jats:p>The antipsychotic clozapine is uniquely effective in the management of schizophrenia; however, its use is limited by its potential to induce agranulocytosis. The causes of this, and of its precursor neutropenia, are largely unknown, although genetic factors have an important role. We sought risk alleles for clozapine-associated neutropenia in a sample of 66 cases and 5583 clozapine-treated controls, through a genome-wide association study (GWAS), imputed human leukocyte antigen (HLA) alleles, exome array and copy-number variation (CNV) analyses. We then combined associated variants in a meta-analysis with data from the Clozapine-Induced Agranulocytosis Consortium (up to 163 cases and 7970 controls). In the largest combined sample to date, we identified a novel association with rs149104283 (odds ratio (OR)=4.32, <jats:italic>P<\/jats:italic>=1.79 \u00d7 10<jats:sup>\u22128<\/jats:sup>), intronic to transcripts of <jats:italic>SLCO1B3<\/jats:italic> and <jats:italic>SLCO1B7<\/jats:italic>, members of a family of hepatic transporter genes previously implicated in adverse drug reactions including simvastatin-induced myopathy and docetaxel-induced neutropenia. Exome array analysis identified gene-wide associations of uncommon non-synonymous variants within <jats:italic>UBAP2<\/jats:italic> and <jats:italic>STARD9<\/jats:italic>. We additionally provide independent replication of a previously identified variant in <jats:italic>HLA-DQB1<\/jats:italic> (OR=15.6, <jats:italic>P<\/jats:italic>=0.015, positive predictive value=35.1%). These results implicate biological pathways through which clozapine may act to cause this serious adverse effect.<\/jats:p>","DOI":"10.1038\/mp.2016.97","type":"journal-article","created":{"date-parts":[[2016,7,12]],"date-time":"2016-07-12T08:04:26Z","timestamp":1468310666000},"page":"1502-1508","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":63,"title":["Genome-wide common and rare variant analysis provides novel insights into clozapine-associated neutropenia"],"prefix":"10.1038","volume":"22","author":[{"name":"Clozapine-Induced Agranulocytosis Consortium","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"S E","family":"Legge","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M L","family":"Hamshere","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3622-835X","authenticated-orcid":false,"given":"S","family":"Ripke","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"A F","family":"Pardinas","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"J I","family":"Goldstein","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"E","family":"Rees","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"A L","family":"Richards","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"G","family":"Leonenko","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"L F","family":"Jorskog","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"K D","family":"Chambert","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"D A","family":"Collier","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"G","family":"Genovese","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"I","family":"Giegling","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"P","family":"Holmans","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"A","family":"Jonasdottir","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"G","family":"Kirov","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"S A","family":"McCarroll","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"J H","family":"MacCabe","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"K","family":"Mantripragada","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"J L","family":"Moran","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"B M","family":"Neale","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"H","family":"Stefansson","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"D","family":"Rujescu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M J","family":"Daly","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"P F","family":"Sullivan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M J","family":"Owen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M C","family":"O'Donovan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"J T R","family":"Walters","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2016,7,12]]},"reference":[{"key":"BFmp201697_CR1","doi-asserted-by":"publisher","first-page":"789","DOI":"10.1001\/archpsyc.1988.01800330013001","volume":"45","author":"J Kane","year":"1988","unstructured":"Kane J, Honigfeld G, Singer J, Meltzer H . Clozapine for the treatment-resistant schizophrenic. A double-blind comparison with chlorpromazine. Arch Gen Psychiatry 1988; 45: 789\u2013796.","journal-title":"Arch Gen Psychiatry"},{"key":"BFmp201697_CR2","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1016\/S0140-6736(08)61764-X","volume":"373","author":"S Leucht","year":"2009","unstructured":"Leucht S, Corves C, Arbter D, Engel RR, Li C, Davis JM . Second-generation versus first-generation antipsychotic drugs for schizophrenia: a meta-analysis. Lancet 2009; 373: 31\u201341.","journal-title":"Lancet"},{"key":"BFmp201697_CR3","unstructured":"Royal College of Psychiatrists. Report of the National Audit of Schizophrenia (NAS) 2012. Healthcare Quality Improvement Partnership, London, 2012."},{"key":"BFmp201697_CR4","doi-asserted-by":"publisher","first-page":"483","DOI":"10.1192\/bjp.169.4.483","volume":"169","author":"K Atkin","year":"1996","unstructured":"Atkin K, Kendall F, Gould D, Freeman H, Liberman J, O'Sullivan D . Neutropenia and agranulocytosis in patients receiving clozapine in the UK and Ireland. Br J Psychiatry 1996; 169: 483\u2013488.","journal-title":"Br J Psychiatry"},{"key":"BFmp201697_CR5","doi-asserted-by":"publisher","first-page":"425","DOI":"10.1192\/bjp.bp.112.114777","volume":"201","author":"MX Patel","year":"2012","unstructured":"Patel MX . Clinician hesitation prior to clozapine initiation: is it justifiable? Br J Psychiatry 2012; 201: 425\u2013427.","journal-title":"Br J Psychiatry"},{"key":"BFmp201697_CR6","doi-asserted-by":"publisher","first-page":"4757","DOI":"10.1038\/ncomms5757","volume":"5","author":"JI Goldstein","year":"2014","unstructured":"Goldstein JI, Fredrik Jarskog L, Hilliard C, Alfirevic A, Duncan L, Fourches D et al. Clozapine-induced agranulocytosis is associated with rare HLA-DQB1 and HLA-B alleles. Nat Commun 2014; 5: 4757.","journal-title":"Nat Commun"},{"key":"BFmp201697_CR7","doi-asserted-by":"publisher","first-page":"421","DOI":"10.1038\/nature13595","volume":"511","author":"Schizophrenia Working Group of the Psychiatric Genomics Consortium","year":"2014","unstructured":"Schizophrenia Working Group of the Psychiatric Genomics Consortium. Biological insights from 108 schizophrenia-associated genetic loci. Nature 2014; 511: 421\u2013427.","journal-title":"Nature"},{"key":"BFmp201697_CR8","doi-asserted-by":"publisher","first-page":"108","DOI":"10.1192\/bjp.bp.113.131052","volume":"204","author":"E Rees","year":"2014","unstructured":"Rees E, Walters JT, Georgieva L, Isles AR, Chambert KD, Richards AL et al. Analysis of copy number variations at 15 schizophrenia-associated loci. Br J Psychiatry 2014; 204: 108\u2013114.","journal-title":"Br J Psychiatry"},{"key":"BFmp201697_CR9","doi-asserted-by":"publisher","first-page":"844","DOI":"10.1002\/ajmg.b.31231","volume":"156B","author":"LS Carroll","year":"2011","unstructured":"Carroll LS, Williams HJ, Walters J, Kirov G, O'Donovan MC, Owen MJ . Mutation screening of the 3q29 microdeletion syndrome candidate genes DLG1 and PAK2 in schizophrenia. Am J Med Genet B Neuropsychiatr Genet 2011; 156B: 844\u2013849.","journal-title":"Am J Med Genet B Neuropsychiatr Genet"},{"key":"BFmp201697_CR10","doi-asserted-by":"publisher","first-page":"403","DOI":"10.1038\/mp.2013.74","volume":"19","author":"AK Tiwari","year":"2014","unstructured":"Tiwari AK, Need AC, Lohoff FW, Zai CC, Chowdhury NI, Muller DJ et al. Exome sequence analysis of Finnish patients with clozapine-induced agranulocytosis. Mol Psychiatry 2014; 19: 403\u2013405.","journal-title":"Mol Psychiatry"},{"key":"BFmp201697_CR11","doi-asserted-by":"publisher","first-page":"e1000529","DOI":"10.1371\/journal.pgen.1000529","volume":"5","author":"BN Howie","year":"2009","unstructured":"Howie BN, Donnelly P, Marchini J . A flexible and accurate genotype imputation method for the next generation of genome-wide association studies. PLoS Genet 2009; 5: e1000529.","journal-title":"PLoS Genet"},{"key":"BFmp201697_CR12","doi-asserted-by":"publisher","first-page":"904","DOI":"10.1038\/ng1847","volume":"38","author":"AL Price","year":"2006","unstructured":"Price AL, Patterson NJ, Plenge RM, Weinblatt ME, Shadick NA, Reich D . Principal components analysis corrects for stratification in genome-wide association studies. Nat Genet 2006; 38: 904\u2013909.","journal-title":"Nat Genet"},{"key":"BFmp201697_CR13","doi-asserted-by":"publisher","first-page":"559","DOI":"10.1086\/519795","volume":"81","author":"S Purcell","year":"2007","unstructured":"Purcell S, Neale B, Todd-Brown K, Thomas L, Ferreira MA, Bender D et al. PLINK: a tool set for whole-genome association and population-based linkage analyses. Am J Hum Genet 2007; 81: 559\u2013575.","journal-title":"Am J Hum Genet"},{"key":"BFmp201697_CR14","doi-asserted-by":"publisher","first-page":"714","DOI":"10.1038\/gim.2014.180","volume":"17","author":"GA Erikson","year":"2015","unstructured":"Erikson GA, Deshpande N, Kesavan BG, Torkamani A . SG-ADVISER CNV: copy-number variant annotation and interpretation. Genet Med 2015; 17: 714\u2013718.","journal-title":"Genet Med"},{"key":"BFmp201697_CR15","doi-asserted-by":"publisher","first-page":"e64683","DOI":"10.1371\/journal.pone.0064683","volume":"8","author":"X Jia","year":"2013","unstructured":"Jia X, Han B, Onengut-Gumuscu S, Chen WM, Concannon PJ, Rich SS et al. Imputing amino acid polymorphisms in human leukocyte antigens. PloS One 2013; 8: e64683.","journal-title":"PloS One"},{"key":"BFmp201697_CR16","doi-asserted-by":"publisher","first-page":"1084","DOI":"10.1086\/521987","volume":"81","author":"SR Browning","year":"2007","unstructured":"Browning SR, Browning BL . Rapid and accurate haplotype phasing and missing-data inference for whole-genome association studies by use of localized haplotype clustering. Am J Hum Genet 2007; 81: 1084\u20131097.","journal-title":"Am J Hum Genet"},{"key":"BFmp201697_CR17","doi-asserted-by":"publisher","first-page":"458","DOI":"10.4088\/JCP.09m05527yel","volume":"72","author":"MC Athanasiou","year":"2011","unstructured":"Athanasiou MC, Dettling M, Cascorbi I, Mosyagin I, Salisbury BA, Pierz KA et al. Candidate gene analysis identifies a polymorphism in HLA-DQB1 associated with clozapine-induced agranulocytosis. J Clin Psychiatry 2011; 72: 458\u2013463.","journal-title":"J Clin Psychiatry"},{"key":"BFmp201697_CR18","doi-asserted-by":"publisher","first-page":"e128","DOI":"10.1093\/nar\/gkl679","volume":"34","author":"IV Kutyavin","year":"2006","unstructured":"Kutyavin IV, Milesi D, Belousov Y, Podyminogin M, Vorobiev A, Gorn V et al. A novel endonuclease IV post-PCR genotyping system. Nucleic Acids Res 2006; 34: e128.","journal-title":"Nucleic Acids Res"},{"key":"BFmp201697_CR19","doi-asserted-by":"publisher","first-page":"1001","DOI":"10.1093\/hmg\/ddv620","volume":"25","author":"AL Richards","year":"2016","unstructured":"Richards AL, Leonenko G, Walters JT, Kavanagh DH, Rees EG, Evans A et al. Exome arrays capture polygenic rare variant contributions to schizophrenia. Hum Mol Genet 2016; 25: 1001\u20131007.","journal-title":"Hum Mol Genet"},{"key":"BFmp201697_CR20","doi-asserted-by":"publisher","first-page":"224","DOI":"10.1016\/j.ajhg.2012.06.007","volume":"91","author":"S Lee","year":"2012","unstructured":"Lee S, Emond MJ, Bamshad MJ, Barnes KC, Rieder MJ, Nickerson DA et al. Optimal unified approach for rare-variant association testing with application to small-sample case-control whole-exome sequencing studies. Am J Hum Genet 2012; 91: 224\u2013237.","journal-title":"Am J Hum Genet"},{"key":"BFmp201697_CR21","doi-asserted-by":"publisher","first-page":"1302","DOI":"10.1038\/mp.2012.142","volume":"18","author":"EK Green","year":"2013","unstructured":"Green EK, Hamshere M, Forty L, Gordon-Smith K, Fraser C, Russell E et al. Replication of bipolar disorder susceptibility alleles and identification of two novel genome-wide significant associations in a new bipolar disorder case-control sample. Mol Psychiatry 2013; 18: 1302\u20131307.","journal-title":"Mol Psychiatry"},{"key":"BFmp201697_CR22","doi-asserted-by":"publisher","first-page":"2190","DOI":"10.1093\/bioinformatics\/btq340","volume":"26","author":"CJ Willer","year":"2010","unstructured":"Willer CJ, Li Y, Abecasis GR . METAL: fast and efficient meta-analysis of genomewide association scans. Bioinformatics 2010; 26: 2190\u20132191.","journal-title":"Bioinformatics"},{"key":"BFmp201697_CR23","doi-asserted-by":"publisher","first-page":"469","DOI":"10.1038\/nature13127","volume":"508","author":"DG MacArthur","year":"2014","unstructured":"MacArthur DG, Manolio TA, Dimmock DP, Rehm HL, Shendure J, Abecasis GR et al. Guidelines for investigating causality of sequence variants in human disease. Nature 2014; 508: 469\u2013476.","journal-title":"Nature"},{"key":"BFmp201697_CR24","doi-asserted-by":"publisher","first-page":"23161","DOI":"10.1074\/jbc.M001448200","volume":"275","author":"J Konig","year":"2000","unstructured":"Konig J, Cui Y, Nies AT, Keppler D . Localization and genomic organization of a new hepatocellular organic anion transporting polypeptide. J Biol Chem 2000; 275: 23161\u201323168.","journal-title":"J Biol Chem"},{"key":"BFmp201697_CR25","doi-asserted-by":"publisher","first-page":"215","DOI":"10.1038\/nrd3028","volume":"9","author":"KM Giacomini","year":"2010","unstructured":"International Transporter Consortium, Giacomini KM, Huang SM, Tweedie DJ, Benet LZ, Brouwer KL et al. Membrane transporters in drug development. Nat Rev Drug Discov 2010; 9: 215\u2013236.","journal-title":"Nat Rev Drug Discov"},{"key":"BFmp201697_CR26","doi-asserted-by":"publisher","first-page":"789","DOI":"10.1056\/NEJMoa0801936","volume":"359","author":"E Link","year":"2008","unstructured":"Search Collaborative Group, Link E, Parish S, Armitage J, Bowman L, Heath S et al. SLCO1B1 variants and statin-induced myopathy\u2014a genomewide study. N Engl J Med 2008; 359: 789\u2013799.","journal-title":"N Engl J Med"},{"key":"BFmp201697_CR27","doi-asserted-by":"publisher","first-page":"423","DOI":"10.1038\/clpt.2014.125","volume":"96","author":"LB Ramsey","year":"2014","unstructured":"Ramsey LB, Johnson SG, Caudle KE, Haidar CE, Voora D, Wilke RA et al. The clinical pharmacogenetics implementation consortium guideline for SLCO1B1 and simvastatin-induced myopathy: 2014 update. Clin Pharmacol Ther 2014; 96: 423\u2013428.","journal-title":"Clin Pharmacol Ther"},{"key":"BFmp201697_CR28","doi-asserted-by":"publisher","first-page":"967","DOI":"10.1111\/j.1349-7006.2008.00765.x","volume":"99","author":"K Kiyotani","year":"2008","unstructured":"Kiyotani K, Mushiroda T, Kubo M, Zembutsu H, Sugiyama Y, Nakamura Y . Association of genetic polymorphisms in SLCO1B3 and ABCC2 with docetaxel-induced leukopenia. Cancer Sci 2008; 99: 967\u2013972.","journal-title":"Cancer Sci"},{"key":"BFmp201697_CR29","doi-asserted-by":"publisher","first-page":"114","DOI":"10.1248\/bpb.34.114","volume":"34","author":"T Nambu","year":"2011","unstructured":"Nambu T, Hamada A, Nakashima R, Yuki M, Kawaguchi T, Mitsuya H et al. Association of SLCO1B3 polymorphism with intracellular accumulation of imatinib in leukocytes in patients with chronic myeloid leukemia. Biol Pharm Bull 2011; 34: 114\u2013119.","journal-title":"Biol Pharm Bull"},{"key":"BFmp201697_CR30","first-page":"244","volume":"33","author":"Y Yamakawa","year":"2011","unstructured":"Yamakawa Y, Hamada A, Nakashima R, Yuki M, Hirayama C, Kawaguchi T et al. Association of genetic polymorphisms in the influx transporter SLCO1B3 and the efflux transporter ABCB1 with imatinib pharmacokinetics in patients with chronic myeloid leukemia. Ther Drug Monit 2011; 33: 244\u2013250.","journal-title":"Ther Drug Monit"},{"key":"BFmp201697_CR31","doi-asserted-by":"publisher","first-page":"606","DOI":"10.1111\/j.1365-2125.2011.04123.x","volume":"73","author":"SC Chew","year":"2012","unstructured":"Chew SC, Sandanaraj E, Singh O, Chen X, Tan EH, Lim WT et al. Influence of SLCO1B3 haplotype-tag SNPs on docetaxel disposition in Chinese nasopharyngeal cancer patients. Br J Clin Pharmacol 2012; 73: 606\u2013618.","journal-title":"Br J Clin Pharmacol"},{"key":"BFmp201697_CR32","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1038\/npp.1994.34","volume":"11","author":"M Hasegawa","year":"1994","unstructured":"Hasegawa M, Cola PA, Meltzer HY . Plasma clozapine and desmethylclozapine levels in clozapine-induced agranulocytosis. Neuropsychopharmacology 1994; 11: 45\u201347.","journal-title":"Neuropsychopharmacology"},{"key":"BFmp201697_CR33","doi-asserted-by":"publisher","first-page":"610","DOI":"10.1176\/ajp.152.4.610","volume":"152","author":"F Centorrino","year":"1995","unstructured":"Centorrino F, Baldessarini RJ, Flood JG, Kando JC, Frankenburg FR . Relation of leukocyte counts during clozapine treatment to serum concentrations of clozapine and metabolites. Am J Psychiatry 1995; 152: 610\u2013612.","journal-title":"Am J Psychiatry"},{"key":"BFmp201697_CR34","doi-asserted-by":"publisher","first-page":"341","DOI":"10.1007\/s002130050628","volume":"137","author":"MC Mauri","year":"1998","unstructured":"Mauri MC, Rudelli R, Bravin S, Gianetti S, Giuliani E, Guerrini A et al. Clozapine metabolism rate as a possible index of drug-induced granulocytopenia. Psychopharmacology 1998; 137: 341\u2013344.","journal-title":"Psychopharmacology"},{"key":"BFmp201697_CR35","doi-asserted-by":"publisher","first-page":"139","DOI":"10.2165\/00023210-199707020-00005","volume":"7","author":"M Pirmohamed","year":"1997","unstructured":"Pirmohamed M, Park K . Mechanism of clozapine-induced agranulocytosis: current status of research and implications for drug development. CNS Drugs 1997; 7: 139\u2013158.","journal-title":"CNS Drugs"},{"key":"BFmp201697_CR36","doi-asserted-by":"publisher","first-page":"207","DOI":"10.1124\/mol.58.1.207","volume":"58","author":"DP Williams","year":"2000","unstructured":"Williams DP, Pirmohamed M, Naisbitt DJ, Uetrecht JP, Park BK . Induction of metabolism-dependent and -independent neutrophil apoptosis by clozapine. Mol Pharmacol 2000; 58: 207\u2013216.","journal-title":"Mol Pharmacol"},{"key":"BFmp201697_CR37","doi-asserted-by":"publisher","first-page":"783","DOI":"10.1016\/j.bcp.2006.06.006","volume":"72","author":"A Pereira","year":"2006","unstructured":"Pereira A, Dean B . Clozapine bioactivation induces dose-dependent, drug-specific toxicity of human bone marrow stromal cells: a potential in vitro system for the study of agranulocytosis. Biochem Pharmacol 2006; 72: 783\u2013793.","journal-title":"Biochem Pharmacol"},{"key":"BFmp201697_CR38","doi-asserted-by":"publisher","first-page":"1309","DOI":"10.1016\/j.cell.2011.11.020","volume":"147","author":"JZ Torres","year":"2011","unstructured":"Torres JZ, Summers MK, Peterson D, Brauer MJ, Lee J, Senese S et al. The STARD9\/Kif16a kinesin associates with mitotic microtubules and regulates spindle pole assembly. Cell 2011; 147: 1309\u20131323.","journal-title":"Cell"},{"key":"BFmp201697_CR39","doi-asserted-by":"publisher","first-page":"114","DOI":"10.1016\/j.cyto.2008.04.015","volume":"43","author":"TL Kindwall-Keller","year":"2008","unstructured":"Kindwall-Keller TL, Druhan LJ, Ai J, Hunter MG, Massullo P, Loveland M et al. Role of the proteasome in modulating native G-CSFR expression. Cytokine 2008; 43: 114\u2013123.","journal-title":"Cytokine"},{"key":"BFmp201697_CR40","doi-asserted-by":"publisher","first-page":"e3422","DOI":"10.1371\/journal.pone.0003422","volume":"3","author":"J Ai","year":"2008","unstructured":"Ai J, Druhan LJ, Loveland MJ, Avalos BR . G-CSFR ubiquitination critically regulates myeloid cell survival and proliferation. PLoS One 2008; 3: e3422.","journal-title":"PLoS One"},{"key":"BFmp201697_CR41","doi-asserted-by":"crossref","first-page":"1177","DOI":"10.1182\/blood.V86.3.1177.1177","volume":"86","author":"JJ Yunis","year":"1995","unstructured":"Yunis JJ, Corzo D, Salazar M, Lieberman JA, Howard A, Yunis EJ . HLA associations in clozapine-induced agranulocytosis. Blood 1995; 86: 1177\u20131183.","journal-title":"Blood"},{"key":"BFmp201697_CR42","doi-asserted-by":"publisher","first-page":"135","DOI":"10.1097\/00008571-200103000-00004","volume":"11","author":"M Dettling","year":"2001","unstructured":"Dettling M, Schaub RT, Mueller-Oerlinghausen B, Roots I, Cascorbi I . Further evidence of human leukocyte antigen-encoded susceptibility to clozapine-induced agranulocytosis independent of ancestry. Pharmacogenetics 2001; 11: 135\u2013141.","journal-title":"Pharmacogenetics"},{"key":"BFmp201697_CR43","doi-asserted-by":"publisher","first-page":"461","DOI":"10.1038\/tpj.2015.5","volume":"15","author":"M Verbelen","year":"2015","unstructured":"Verbelen M, Collier DA, Cohen D, MacCabe JH, Lewis CM . Establishing the characteristics of an effective pharmacogenetic test for clozapine-induced agranulocytosis. Pharmacogenomics J 2015; 15: 461\u2013466.","journal-title":"Pharmacogenomics J"}],"updated-by":[{"DOI":"10.1038\/mp.2016.137","type":"erratum","label":"Erratum","source":"publisher","updated":{"date-parts":[[2016,8,9]],"date-time":"2016-08-09T00:00:00Z","timestamp":1470700800000}},{"DOI":"10.1038\/mp.2017.214","type":"erratum","label":"Erratum","source":"publisher","updated":{"date-parts":[[2017,10,24]],"date-time":"2017-10-24T00:00:00Z","timestamp":1508803200000}}],"container-title":["Molecular Psychiatry"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/www.nature.com\/articles\/mp201697.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/mp201697","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/doifinder\/10.1038\/mp.2016.97","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"},{"URL":"http:\/\/www.nature.com\/articles\/mp201697.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,5,18]],"date-time":"2023-05-18T18:16:49Z","timestamp":1684433809000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/mp201697"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,7,12]]},"references-count":43,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2017,10]]}},"alternative-id":["BFmp201697"],"URL":"https:\/\/doi.org\/10.1038\/mp.2016.97","relation":{"erratum":[{"id-type":"doi","id":"10.1038\/mp.2016.137","asserted-by":"object"},{"id-type":"doi","id":"10.1038\/mp.2017.214","asserted-by":"object"}]},"ISSN":["1359-4184","1476-5578"],"issn-type":[{"value":"1359-4184","type":"print"},{"value":"1476-5578","type":"electronic"}],"subject":[],"published":{"date-parts":[[2016,7,12]]},"assertion":[{"value":"21 January 2016","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"10 May 2016","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"17 May 2016","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"12 July 2016","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"LFJ has received research grant support from Teva\/Auspex Pharmaceuticals and has served on a Data Safety and Monitoring Board for Janssen. DAC is a full-time employee and stockholder of Eli Lilly and Company. The remaining authors declare no conflicts of interest.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}]}}